Evaluation of a rapid antigen detection test (Panbio™ COVID‐19 Ag Rapid Test Device) as a point‐of‐care diagnostic tool for COVID‐19 in a pediatric emergency department
Silvia Carbonell‐Sahuquillo, María Isabel Lázaro Carreño, Jorge Camacho, Ana Barrés‐Fernández, Eliseo Albert, Ignacio Torres, José Rafael Bretón-Martínez, Cecilia Martínez‐Costa, David Navarro
Abstract
We evaluated the Panbio™ COVID-19 Ag Rapid Test Device as a point-of-care diagnostic tool for COVID-19 in 357 patients at a pediatric emergency department. Thirty-four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sensitivity and specificity of the assay were 70.5% and 100%, respectively.
Topics & Concepts
VirologyPoint-of-care testingCoronavirus disease 2019 (COVID-19)Emergency departmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineRapid diagnostic testPoint of care2019-20 coronavirus outbreakDiagnostic testAntigenImmunologyEmergency medicineInternal medicineInfectious disease (medical specialty)PathologyDiseasePsychiatryOutbreakSARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchBiosensors and Analytical Detection